Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2012
06/07/2012CA2819734A1 Carbocycle-substituted purine and 7-deazapurine compounds
06/07/2012CA2819648A1 Substituted purine and 7-deazapurine compounds
06/07/2012CA2819625A1 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
06/07/2012CA2819619A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819530A1 Cytotoxicity-inducing therapeutic agent
06/07/2012CA2819512A1 Novel topical composition of sarracenia purpurea (pitcher plant)
06/07/2012CA2819504A1 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012CA2819468A1 Chemokine cxcr4 receptor modulators and used related thereto
06/07/2012CA2819463A1 Tomm34 peptides and vaccines including the same
06/07/2012CA2819399A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
06/07/2012CA2819240A1 Aptamer bioconjugate drug delivery device
06/07/2012CA2819215A1 Pyrazole compounds having therapeutic effect on multiple myeloma
06/07/2012CA2819187A1 Covalently dimerized bivalent binding agents
06/07/2012CA2819009A1 Substituted benzopyrazin derivatives as fgfr kinase inhibitors for the treatment of cancer diseases
06/07/2012CA2818713A1 Process for the preparation of morpholinyl anthracycline derivatives
06/07/2012CA2818187A1 Bromodomain inhibitors and uses thereof
06/07/2012CA2817968A1 Combination of checkpoint kinase 1 inhibitors and wee 1 kinase inhibitors
06/07/2012CA2817618A1 Pharmaceutical compositions
06/07/2012CA2814595A1 Anticancer fusion protein
06/06/2012EP2460832A2 TWEAK binding antibodies
06/06/2012EP2460831A2 Tweak binding antibodies
06/06/2012EP2460814A1 Peptidic compound and use of same
06/06/2012EP2460812A1 Sterol derivatives and their synthesis and use
06/06/2012EP2460805A1 Fused imidazole derivative having ttk inhibitory action
06/06/2012EP2460793A1 Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles And Their Use as Tubulin Polymerisation Inhibitors
06/06/2012EP2460538A1 Cancer metastasis inhibitor
06/06/2012EP2460522A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
06/06/2012EP2459592A1 High affinity human antibodies to human angiopoietin-2
06/06/2012EP2459591A1 Inhibition of tumor metastasis using bv8- or g-csf-antagonists
06/06/2012EP2459589A1 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/06/2012EP2459581A2 Liver x receptor agonists
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459567A2 Phthalocyanine derivative consisting of a mixture of 4 isomers
06/06/2012EP2459562A1 Pyrrolo [1, 2-b]pyridazine derivatives as janus kinase inhibitors
06/06/2012EP2459561A1 Poly (adp-ribose) polymerase (parp) inhibitors
06/06/2012EP2459559A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
06/06/2012EP2459556A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
06/06/2012EP2459553A1 Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
06/06/2012EP2459543A1 Benzo [e][1, 3]oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
06/06/2012EP2459535A1 Pyridine and pyrazine derivatives as protein kinase modulators
06/06/2012EP2459533A1 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
06/06/2012EP2459532A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process
06/06/2012EP2459517A1 Polymorphic form of toremifene citrate and process for its preparation
06/06/2012EP2459510A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
06/06/2012EP2459233A1 Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer
06/06/2012EP2459199A1 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer
06/06/2012EP2459196A1 Plk inhibitor salts
06/06/2012EP2459189A1 Fatty acids as anti-inflammatory agents
06/06/2012EP2459173A1 Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
06/06/2012EP2459169A1 Bladder instillation compositions for treating bladder cancer
06/06/2012EP2220092B1 Azaindolizines and methods of use
06/06/2012EP2213679B1 Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
06/06/2012EP2196475B1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/06/2012EP2137188B1 Substituted imidazopyrimidines and triazolopyrimidines
06/06/2012EP2128261B1 A recombinant adenovirus comprising recombinant khp53 gene and preparation method and uses thereof
06/06/2012EP2115003B1 Human antibodies to human delta like ligand 4
06/06/2012EP2061814B1 Antibodies and immunoconjugates and uses therefor
06/06/2012EP2032172B1 Leptomycin derivatives
06/06/2012EP2004693B1 Compositions and methods of use for antibodies of c-met
06/06/2012EP1967209B1 Therapeutic agent for prostate cancer
06/06/2012EP1858879B1 1,3-diaryl substituted ureas as modulators of kinase activity
06/06/2012EP1787653B1 Antitumoral pharmaceutical composition containing polypeptide fragments of serralysins
06/06/2012EP1711188B1 Anti-cancer therapies
06/06/2012EP1633718B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-s
06/06/2012EP1616575B1 Method for treating inflammation
06/06/2012EP1568775B1 Cancer-associated gene
06/06/2012EP1557415B1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
06/06/2012EP1463558B1 Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
06/06/2012DE112010003137T5 Prophylaxe gegen krebsmetastasierung Prophylaxis against cancer metastasis
06/06/2012DE102010053347A1 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren 3-hetaryl-substituted pyrrolo [2,3-b] pyridine-derivative as PDK1 inhibitors
06/06/2012CN1561343B Soluble T cell receptor
06/06/2012CN1545508B 1,2,4-trioxolane antimalarials
06/06/2012CN1309563B Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action
06/06/2012CN102485753A Human derived heavy chain variable region possessing human vascular endothelial growth factor binding activity
06/06/2012CN102485743A Antineoplastic compound
06/06/2012CN102485741A Methyl reduced oleanane triterpenoid, its preparation method and application
06/06/2012CN102485735A 6-fructosamine-4-arylamidoquinazoline derivative and purpose thereof
06/06/2012CN102485721A Substituted 2,3-phthalazinone compounds and application thereof
06/06/2012CN102485720A Heat shock protein 90 inhibitor
06/06/2012CN102485278A Preparation of polycaprolactone embolism microballoon
06/06/2012CN102485274A Preparation method and use of poly(lactic-co-glycolic acid) (PLGA) microspheres as nucleic acid vaccine vectors
06/06/2012CN102485237A Sweet wormwood herb brewed liquid, brewing technology thereof, and preparation method of starter thereof
06/06/2012CN102485217A Letrozole tablet with high dissolubility and preparation method thereof
06/06/2012CN102485213A Irinotecan liposome and preparation method thereof
06/06/2012CN102485212A Sunitinib malate liposome and preparation method thereof
06/06/2012CN102485211A Doxorubicin liposome and its preparation method
06/06/2012CN102125681B Anticancer medicinal patch
06/06/2012CN102068411B Carbazole sulfonamide type anti-tumor medicament granules and preparation method thereof
06/06/2012CN102061310B Construction and application of human FHL1C eukaryotic expression vector
06/06/2012CN102020765B Preparation methods of poly (aspartic acid-co-lactic acid) graft polymer and nanoparticles of poly (aspartic acid-co-lactic acid) graft polymer
06/06/2012CN102008725B Application of human UTP14a expression inhibitor in preparation of cell proliferation inhibitor
06/06/2012CN102008496B Medicament for treating breast cancer and preparation method thereof
06/06/2012CN101991608B Fly maggot extractive as well as preparation method and application thereof
06/06/2012CN101972247B Medicinal application of 15-benzyl subunit-1 4-deoxy-11,12-dehydrogenation andrographolide derivative
06/06/2012CN101954022B Chinese medicinal composition for treating lung cancer
06/06/2012CN101948428B 1-methyl-5H-indene (1,2-b) pyridine trifluoromethanesulfonic salt-5-(4-dimethylamino group) benzylidene derivative and preparation method thereof
06/06/2012CN101940708B Traditional Chinese medicinal preparation for curing malignant pleural effusion
06/06/2012CN101919974B Traditional Chinese medicinal composition for treating glioma and preparation method thereof
06/06/2012CN101816797B Gold nanoparticles used as medicament carrier and method for preparing same
06/06/2012CN101791325B Preparation method of Chinese goosebeery capsule for preventing and treating lung cancer
1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 2211